Clinical Trial

Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2021 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an experimental study to evaluate the safety and efficacy of CAR T cells targeting CAIX in the treatment of advanced renal cancer.
Trial Details
NCT Number NCT04969354
Lead Sponsor The Affiliated Hospital of Xuzhou Medical University
Collaborators: Xuzhou Medical University
Conditions Immunotherapy
Enrollment 20 participants
Start Date 2021-10-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2021-07-20